321 filings
6-K
BLU
Bellus Health Inc
28 Jun 23
Material Change Report
2:42pm
6-K
BLU
Bellus Health Inc
28 Jun 23
GSK completes acquisition of BELLUS Health
11:05am
6-K
BLU
Bellus Health Inc
16 Jun 23
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
4:21pm
6-K
BLU
Bellus Health Inc
6 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:05pm
6-K
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
6-K
l4dnp6
19 May 23
Current report (foreign)
5:27pm
6-K
v7x9roqz bpiodb
16 May 23
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
5:04pm
6-K
600f 7xf06
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
6-K
v3qr296
12 May 23
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
4:02pm
6-K
idks8550b
28 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
3:01pm
6-K
bxd3tx1
28 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
11:13am
6-K
xn4815
27 Apr 23
Material Change Report
6:04am
6-K
ehswdc5
26 Apr 23
BELLUS Health Announces Meeting Updates
6:00pm
6-K
5zcma 7h493j9bh
24 Apr 23
Report of Foreign Private Issuer for the Month of April 2023
7:05pm
6-K
1ysrmcda6d 49ny
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
6-K
9v0f5ug1vhs8l
5 Apr 23
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating
7:01am
6-K
qz3t7r
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
8oz6fnhc3l awop5cuzh
29 Mar 23
Current report (foreign)
5:26pm
6-K
9mm zlabeaoaf7
21 Mar 23
Investor Presentation NASDAQ/TSX - BLU March 21 st , 2023
4:43pm
6-K
mpahxzifp7n05src3
21 Mar 23
BELLUS Health Reports Year 2022 Financial Results and Business Highlights
4:30pm